Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07226466

Evaluating Biomarkers of Cognitive Dysfunction in Patients With Cancer

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
40 (estimated)
Sponsor
University of California, San Francisco · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study investigates the effects of brain radiotherapy on cognitive function by evaluating plasma biomarkers and apolipoprotein E (APOE) genotype in patients with primary or metastatic brain tumors. Standard brain radiotherapy is known to impact cognitive outcomes, yet the underlying biological mechanisms remain unclear.

Detailed description

PRIMARY OBJECTIVES: 1. Assess plasma biomarkers for Aβ, GFAP, phospho Tau, and NfL pre- and post-radiotherapy. 2. Determine APOE genotype. 3. Evaluate neuropsychiatric testing aligned with standard of care brain MRIs and serum markers. 4. Measure brain morphometrics pre- and post-radiotherapy with standard of care brain MRIs. SECONDARY OBJECTIVES: 1\. Measure patient-reported quality of life changes pre- and post-radiotherapy using a standard University of California, San Francisco (UCSF) -approved questionnaire. OUTLINE: This is a single-arm, non-randomized, open-label pilot study. Participants will be study duration spans 12 months post-brain radiotherapy.

Conditions

Interventions

TypeNameDescription
PROCEDUREBlood sampleBlood sample will be collected
PROCEDUREBrain magnetic resonance imaging (MRI)Brain MRI will be performed during the course of data collection
PROCEDUREBrain Health AssessmentBrain Health Assessment will be performed during the course of data collection
RADIATIONQuality of Life (QoL) QuestionnaireQoL questionnaire will be given to participants during the course of data collection

Timeline

Start date
2026-03-01
Primary completion
2028-05-31
Completion
2028-05-31
First posted
2025-11-10
Last updated
2025-11-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07226466. Inclusion in this directory is not an endorsement.

Evaluating Biomarkers of Cognitive Dysfunction in Patients With Cancer (NCT07226466) · Clinical Trials Directory